Syrup with ipecac- asuitable emetic for poisoning in children
Cerný, M.
Ceskoslovenska Pediatrie 26(12): 595
1971
ISSN/ISBN: 0069-2328 PMID: 4400371 Document Number: 38360
Document emailed within 1 workday
Related Documents
Krenzelok, E.P.; Dean, B.S. 1987: Effectiveness of 15-mL versus 30-mL doses of syrup of ipecac in children Clinical Pharmacy 6(9): 715-717Mofenson, H.C.; Caraccio, T.R. 1986: Benefits/risks of syrup of ipecac Pediatrics 77(4): 551-552
Yamashita, M.; Yamashita, M.; Fujii, Y. 2001: Pharmacokinetics and tissue distribution of ipecac syrup Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 14(1): 11-15
Frank, R.J.; Bianchi, R.J.; Barnes, W.H. 1989: Cooperative regional program for distribution of poison prevention information and syrup of ipecac American Journal of Hospital Pharmacy 46(4): 719-723
Heremans, G.; Dehaen, F.; Rom, N.; Ramet, J.; Verboven, M.; Loeb, H. 1988: A single-blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children British Journal of Clinical Practice 42(6): 245-247
Simon, O.R.; Chang, C. 1994: Demonstration of bioequivalence between ventasol syrup and ventolin syrup in humans and in dogs West Indian Medical Journal 43(2): 39-42
Von Szeged, A.V.; Michos, N. 1986: Controlled single-blind clinical study of suprofen syrup versus metamizole syrup Arzneimittel-Forschung 36(7): 1110-1112
Arata, J.; Yamamoto, Y.; Hagiyama, M.; Nohara, N.; Suwaki, M.; Miyoshi, K.; Masuda, T.; Nakagawa, S.; Ueki, H.; Nakakita, T.; Kashiwa, N.; Tokumaru, S.; Arakawa, K.; Take, M.; Nishihara, O.; Masuda, T.; Hiramatsu, H.; Yamada, M.; Nishimoto, M.; Tada, J.; Umemura, S.; Fujimoto, W.; Tanaka, A.; Okuma, N. 1981: Use of cefroxadine dry syrup in the management of acute skin infections in children Japanese Journal of Antibiotics 34(12): 1748-1764
Furukawa, S.; Okada, T.; Hirao, F. 1981: Clinical trials with cefroxadine dry syrup in the treatment of infectious disease of children Japanese Journal of Antibiotics 34(12): 1697-1702
Sugita, R.; Yamanaka, N.; Kudo, F.; Ito, R.; Kawai, M.; Ohwaki, I.; Asano, S.; Nagata, T. 2007: Efficacy and safety of potassium clavulanate/amoxicillin (CLAVAMOX) dry syrup in children with otitis media Japanese Journal of Antibiotics 60(4): 221-241
Christen, H.J.; Zink, C.; Zink, A.; Korporal, J. 1981: Accidental poisoning in childhood from the epidemiological viewpoint-An analysis of 323 cases of poisoning in children under eight years of age- Veterinary and Human Toxicology 23(5): 321-327
Peytchev, L.; Chakova, L. 1998: Comparative drug monitoring of carbamazepin suspension (TroyaPharm) and Tegretol syrup (Ciba Geigy) in epileptic children Folia Medica 40(4): 29-33
Franke, P.; Krey, W.D. 1977: Broncho-BINOTAL-syrup for the treatment of inflammatory infections involving respiratory tracts of infants and small children Medizinische Monatsschrift 31(10): 472-475
Lutsky, B.N.; Klöse, P.; Melon, J.; Menardo, J.L.; Molkhou, P.; Ronchetti, R.; Suonpää, J.; Wahn, U.; Wessel, F. 1993: A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis Clinical Therapeutics 15(5): 855-865
Marzian, O. 2007: Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves MMW Fortschritte der Medizin 149(27-28 (Suppl): 69-74
Cooper, C.; Kilham, H.; Ryan, M. 1998: Ipecac--a substance of abuse Medical Journal of Australia 168(2): 94-95
Brushwood, D.B.; Tietze, K.J. 1986: Regulatory controversy surrounding ipecac use and misuse American Journal of Hospital Pharmacy 43(1): 157-161
Smith, E.; Sharkey, M.F.; Levine, J. 1971: Assay of ipecac and its preparations. I. Development of the method Journal - Association of Official Analytical Chemists 54(3): 609-613
Roszkowska, H.; Goryński, P. 1989: Trauma and poisoning in children and adolescents in Poland from 1980-1985 in the light of data on hospitalization. II. Territorial differences in hospitalization of children and adolescents in Poland for trauma and poisoning Przeglad Epidemiologiczny 43(4): 426-432
Schneider, D.J.; Perez, A.; Knilans, T.E.; Daniels, S.R.; Bove, K.E.; Bonnell, H. 1996: Clinical and pathologic aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy Pediatrics 97(6 Part 1): 902-906